We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Takeda Pharmaceutical and Wyeth jointly announced that they have begun distributing
ENBREL, an injection solution for the treatment of rheumatoid arthritis (RA),
March 30. ENBREL, which is currently approved in over 70 countries worldwide,
is the only fully human anti-TNF receptor used as monotherapy for RA patients.
Under the collaboration, Daiichi will utilize Cyntellect's high-throughput cell
imaging and laser-based cell manipulation technology, LEAP, for novel drug discovery.
Roche announced that the European authorities have approved Xeloda (capecitabine),
an innovative oral chemotherapy, to be used as an adjuvant treatment (post-surgery)
for colon cancer.
Cytos Biotechnology AG and Medarex, Inc. announced
that the two companies have expanded the scope of their collaborative research,
development and license agreement for new drug targets.
The Office of the US Trade Representative (USTR) has claimed that
Israel's intellectual property protection regime has led to a downscaling of
involvement by international companies in Israel's drug industry, particularly
in the R&D sector.
A US-based health group, the AIDS Healthcare Foundation (AHF), has called on
government agencies and drug companies in Mexico to reconsider intellectual
property requirements included in the NAFTA treaty.
Reforms introduced last year to Germany's pricing and reimbursement structures
have led small-to-medium-sized drugmakers' revenue and profit levels to fall
by as much as 20%, according to industry association BPI.
Following the introduction of a new bill aiming to create a drug
price control board in Vietnam, senior officials have indicated their displeasure
at new requests to increase prices from a number of drugmakers.
In the midst of a federal inquiry into its accounting for software development
costs and facing financial struggles, NDCHealth Corp. reported today it is up
for sale.